Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
Artemisinin-based combination therapy is exerting novel selective pressure upon populations of Plasmodium falciparum across Africa. Levels of resistance to non-artemisinin partner drugs differ among parasite populations, and so the artemisinins are not uniformly protected from developing resistance,...
Main Authors: | Sutherland, C, Babiker, H, Mackinnon, M, Ranford-Cartwright, L, El Sayed, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Trends in antimalarial drug use in Africa.
by: Flegg, J, et al.
Published: (2013) -
Malaria and safety issues associated with antimalarial drugs
by: A. S. Kazakov, et al.
Published: (2018-02-01) -
Drug resistance in malaria: its population biology and implications for control.
by: Babiker, H, et al.
Published: (2005) -
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (2004) -
Therapeutic responses to different antimalarial drugs in vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (2000)